Literature DB >> 11479558

ADMET--turning chemicals into drugs.

J Hodgson1.   

Abstract

Mesh：

Year:  2001        PMID： 11479558     DOI： 10.1038/90761

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  55 in total

1.  Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity.

Authors:  Dharmendra Kumar Yadav; Feroz Khan; Arvind Singh Negi
Journal:  J Mol Model       Date:  2011-10-27       Impact factor: 1.810

2.  Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver.

Authors:  Xia Yang; Bin Zhang; Cliona Molony; Eugene Chudin; Ke Hao; Jun Zhu; Andrea Gaedigk; Christine Suver; Hua Zhong; J Steven Leeder; F Peter Guengerich; Stephen C Strom; Erin Schuetz; Thomas H Rushmore; Roger G Ulrich; J Greg Slatter; Eric E Schadt; Andrew Kasarskis; Pek Yee Lum
Journal:  Genome Res       Date:  2010-06-10       Impact factor: 9.043

3.  Bioresponsive peptide-polysaccharide nanogels - A versatile delivery system to augment the utility of bioactive cargo.

Authors:  Andrew W Simonson; Atip Lawanprasert; Tyler D P Goralski; Kenneth C Keiler; Scott H Medina
Journal:  Nanomedicine       Date:  2018-11-03       Impact factor: 5.307

4.  Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activity.

Authors:  Komal Kalani; Dharmendra Kumar Yadav; Feroz Khan; Santosh K Srivastava; Nitasha Suri
Journal:  J Mol Model       Date:  2012-01-21       Impact factor: 1.810

5.  A proteomics approach to the study of absorption, distribution, metabolism, excretion, and toxicity.

Authors:  Helena Nordvarg; John Flensburg; Ola Rönn; Johan Ohman; Rita Marouga; Bo Lundgren; Daniel Haid; Eva Malmport; Jan Goscinski; Lena Hörnsten; Michaela Scigelova; Stephanie Bourin; Per Garberg; Gary Woffendin; David Fenyö; Hélène Bergling; Erik Forsberg
Journal:  J Biomol Tech       Date:  2004-12

6.  How "drug-like" are naturally occurring anti-cancer compounds?

Authors:  Fidele Ntie-Kang; Lydia L Lifongo; Philip N Judson; Wolfgang Sippl; Simon M N Efange
Journal:  J Mol Model       Date:  2014-01-24       Impact factor: 1.810

7.  Using Caenorhabditis elegans to study serpinopathies.

Authors:  Olivia S Long; Sager J Gosai; Joon Hyeok Kwak; Dale E King; David H Perlmutter; Gary A Silverman; Stephen C Pak
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

Review 8.  Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis.

Authors:  Mark J Canet; Nathan J Cherrington
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-07-03       Impact factor: 4.481

9.  In silico-based combinatorial pharmacophore modelling and docking studies of GSK-3β and GK inhibitors of Hippophae.

Authors:  Sushil Kumar Middha; Arvind Kumar Goyal; Syed Ahmed Faizan; Nethramurthy Sanghamitra; Bharat Chandra Basistha; Talambedu Usha
Journal:  J Biosci       Date:  2013-11       Impact factor: 1.826

Review 10.  Drug interactions of hepatitis C direct-acting antivirals in the HIV-infected person.

Authors:  O El-Sherif; D Back
Journal:  Curr HIV/AIDS Rep       Date:  2015-09       Impact factor: 5.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.